| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2023 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEWART INFORMATION SVCS COR | 19 | Q4 2017 | 19.7% |
| THERAVANCE BIOPHARMA INC | 17 | Q2 2018 | 6.0% |
| ECHOSTAR CORP | 12 | Q1 2016 | 8.4% |
| NIELSEN HLDGS PLC | 12 | Q2 2018 | 7.4% |
| AMERICAN INTL GROUP INC | 12 | Q2 2016 | 7.8% |
| COPART INC | 11 | Q2 2018 | 19.3% |
| WRIGHT MED GROUP N V | 11 | Q2 2018 | 10.5% |
| WRIGHT MED GROUP INC | 10 | Q3 2015 | 9.0% |
| ENDO INTL PLC | 9 | Q1 2016 | 16.3% |
| CDW CORP | 9 | Q4 2016 | 8.3% |
View Foundation Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| STEWART INFORMATION SERVICES CORP | December 09, 2016 | 1,165,350 | 5.0% |
| NUPATHE INC. | February 10, 2014 | 938,640 | 3.0% |
View Foundation Asset Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
| 13F-HR | 2017-02-14 |
| SC 13D/A | 2016-12-09 |
| 13F-HR | 2016-11-14 |
| DFAN14A | 2016-10-18 |
View Foundation Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.